Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
作者： Timo Rieg , Takahiro Masuda , Maria Gerasimova , Eric Mayoux , Kenneth Platt
DOI: 10.1152/AJPRENAL.00518.2013
关键词:
摘要: … and female Sglt1/Sglt2 double knockout mice. In conclusion, SGLT2 and SGLT1 account for … SGLT2 and SGLT1, respectively. When SGLT2 is fully inhibited by SGLT2-I, the increase in …
researchgate.net 
sci-hub.se 参考文章(20)
Volker Vallon, Michael Rose, Maria Gerasimova, Joseph Satriano, Kenneth A. Platt, Hermann Koepsell, Robyn Cunard, Kumar Sharma, Scott C. Thomson, Timo Rieg, Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus American Journal of Physiology-renal Physiology. ,vol. 304, ,(2013) , 10.1152/AJPRENAL.00409.2012
Ernest M. Wright, Donald D. F. Loo, Bruce A. Hirayama, Biology of Human Sodium Glucose Transporters Physiological Reviews. ,vol. 91, pp. 733- 794 ,(2011) , 10.1152/PHYSREV.00055.2009
R. Grempler, L. Thomas, M. Eckhardt, F. Himmelsbach, A. Sauer, D. E. Sharp, R. A. Bakker, M. Mark, T. Klein, P. Eickelmann, Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes, Obesity and Metabolism. ,vol. 14, pp. 83- 90 ,(2012) , 10.1111/J.1463-1326.2011.01517.X
J. Liu, T. Lee, R. A. DeFronzo, Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans? Diabetes. ,vol. 61, pp. 2199- 2204 ,(2012) , 10.2337/DB12-0052
V. Gorboulev, A. Schurmann, V. Vallon, H. Kipp, A. Jaschke, D. Klessen, A. Friedrich, S. Scherneck, T. Rieg, R. Cunard, M. Veyhl-Wichmann, A. Srinivasan, D. Balen, D. Breljak, R. Rexhepaj, H. E. Parker, F. M. Gribble, F. Reimann, F. Lang, S. Wiese, I. Sabolic, M. Sendtner, H. Koepsell, Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose-Absorption and Glucose-Dependent Incretin Secretion Diabetes. ,vol. 61, pp. 187- 196 ,(2012) , 10.2337/DB11-1029
Volker Vallon, Kenneth A. Platt, Robyn Cunard, Jana Schroth, Jean Whaley, Scott C. Thomson, Hermann Koepsell, Timo Rieg, SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule Journal of The American Society of Nephrology. ,vol. 22, pp. 104- 112 ,(2011) , 10.1681/ASN.2010030246
Joseph P. Ly, Tuncer Onay, Karen Sison, Gavasker Sivaskandarajah, Venkata Sabbisetti, Lingli Li, Joseph V. Bonventre, Ann Flenniken, Neal Paragas, Jon M. Barasch, S. Lee Adamson, Lucy Osborne, Janet Rossant, Jurgen Schnermann, Susan E. Quaggin, The Sweet Pee Model for Sglt2 Mutation Journal of The American Society of Nephrology. ,vol. 22, pp. 113- 123 ,(2011) , 10.1681/ASN.2010080888
B Komoroski, N Vachharajani, D Boulton, D Kornhauser, M Geraldes, L Li, M Pfister, Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects. Clinical Pharmacology & Therapeutics. ,vol. 85, pp. 520- 526 ,(2009) , 10.1038/CLPT.2008.251
René Santer, Joaquim Calado, Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target Clinical Journal of The American Society of Nephrology. ,vol. 5, pp. 133- 141 ,(2010) , 10.2215/CJN.04010609
Volker Vallon, Kumar Sharma, Sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Current Opinion in Nephrology and Hypertension. ,vol. 19, pp. 425- 431 ,(2010) , 10.1097/MNH.0B013E32833BEC06